Isolation of <i>Candida auris</i> from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing

Ana Belén AraúzDiego H. CáceresErika SantiagoPaige A. ArmstrongS Reynaldo ArosemenaCarolina RamosAndrés Espinosa-BodeJovanna BoraceLizbeth HayerIsrael Cedeño2026-03-222026-03-22201710.1111/myc.12709https://doi.org/10.1111/myc.12709https://andeanlibrary.org/handle/123456789/43416Citaciones: 100Candida auris is an emerging multidrug-resistant (MDR) fungus associated with invasive infections and high mortality. This report describes 9 patients from whom C. auris was isolated at a hospital in Panama City, Panama, the first such cases in Central America, and highlights the challenges of accurate identification and methods for susceptibility testing.enCandida aurisPanamaIsolation (microbiology)MedicineFungusIntensive care medicineAntifungalMicrobiologyBiologyIsolation of <i>Candida auris</i> from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testingarticle